Public notice

3,6′- and 1,6′-Dithiopomalidomide Mitigate Ischemic Stroke in Rats and Blunt Inflammation

관리자 │ 2023-01-17

HIT

608

3,6′- and 1,6′-Dithiopomalidomide Mitigate Ischemic Stroke in Rats and Blunt Inflammation, Int Pharmaceutics. (APR 27, 2022).


The publication, titled, "3,6′- and 1,6′-Dithiopomalidomide Mitigate Ischemic Stroke in Rats and Blunt Inflammation"

may be found here (http://doi.org/10.3390/pharmaceutics14050950).


Previous Post Role of chronic neuroinflammation in neuroplasticity and cognitive function: A h...
Next Post Activity of a Novel Anti-Inflammatory Agent F-3,6′-dithiopomalidomide as a Tre...